| 1 |
29957475 | Fibrinolytic potential of DS-1040, a novel orally available inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa). | 2018 Aug |
1 |
| 2 |
28640323 | Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potential. | 2017 Jul 26 |
4 |
| 3 |
27604544 | Isolation, Co-Crystallization and Structure-Based Characterization of Anabaenopeptins as Highly Potent Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa). | 2016 Sep 8 |
1 |
| 4 |
22827639 | Role of thrombin activatable fibrinolysis inhibitor in endocrine and cardiovascular disorders: an update. | 2012 Sep |
2 |
| 5 |
19959491 | Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism. | 2010 Oct |
2 |
| 6 |
19074424 | The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex. | 2009 Mar 13 |
2 |
| 7 |
19790060 | Thrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritis. | 2009 Oct |
1 |
| 8 |
15802136 | Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrate. | 2005 May 1 |
4 |
| 9 |
15946220 | Role of isoleucine residues 182 and 183 in thrombin-activatable fibrinolysis inhibitor. | 2005 Jun |
1 |
| 10 |
15282667 | Association of functional thrombin-activatable fibrinolysis inhibitor (TAFI) with conventional cardiovascular risk factors and its correlation with other hemostatic factors in a Spanish population. | 2004 Aug |
1 |
| 11 |
14567541 | Characterization of thrombin activatable fibrinolysis inhibitor in normal and acquired haemostatic dysfunction. | 2003 Jun |
1 |
| 12 |
11939578 | Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. | 2002 |
3 |
| 13 |
12008932 | Heat stability of carboxypeptidase R of experimental animals. | 2002 |
2 |
| 14 |
12022872 | Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor. | 2002 May 28 |
3 |
| 15 |
11463460 | Substrate specificity of recombinant cysteine proteinase, CPB, of Leishmania mexicana. | 2001 Aug |
1 |
| 16 |
10759708 | Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia. | 2000 Mar |
1 |
| 17 |
10777524 | Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage. | 2000 Apr 28 |
1 |
| 18 |
11215380 | [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)]. | 2000 Nov |
1 |
| 19 |
9162090 | On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B. | 1997 May 30 |
1 |